SHAREHOLDERS at Manchester-based medical firm Intercytex have approved its plans to sell off its assets and leave the Alternative Investment Market (AIM).

The shares will be cancelled on January 8 and the company's name will be changed to Regenerative Medicine Assets.

Job cuts have been made across the group and the only remaining employees are three executive directors. Following completion of the disposals the company will be wound up.

The company, which specialises in regenerative medicine for skin and hair......for the full story register now for free or login below...